{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:02:09Z","timestamp":1790427729623,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.transproceed.2026.07.021","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:12:42Z","timestamp":1787022762000},"page":"1605-1611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-Term Outcomes of Heart Transplantation Using Hepatitis C\u2013Positive Donors"],"prefix":"10.1016","volume":"58","author":[{"given":"You-Min","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Sung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Ming","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Ying","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Yi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.transproceed.2026.07.021_bib0001","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/CIRCULATIONAHA.117.029753","article-title":"Honoring 50 years of clinical heart transplantation in circulation: in-depth state-of-the-art review","volume":"137","author":"Stehlik","year":"2018","journal-title":"Circulation"},{"issue":"2s1","key":"10.1016\/j.transproceed.2026.07.021_bib0002","article-title":"OPTN\/SRTR 2022 Annual Data Report: Heart","volume":"24","author":"Colvin","year":"2024","journal-title":"Am J Transplant"},{"issue":"15","key":"10.1016\/j.transproceed.2026.07.021_bib0003","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019655","article-title":"National trends in heart donor usage rates: are we efficiently transplanting more hearts?","volume":"10","author":"Dharmavaram","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.transproceed.2026.07.021_bib0004","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.athoracsur.2019.03.076","article-title":"Impact of the opioid epidemic on heart transplantation: donor characteristics and organ discard","volume":"108","author":"Phillips","year":"2019","journal-title":"Ann Thorac Surg"},{"issue":"Suppl 3","key":"10.1016\/j.transproceed.2026.07.021_bib0005","article-title":"Policy and strategy for hepatitis C virus elimination at the national level: experience in Taiwan","volume":"228","author":"Chien","year":"2023","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.transproceed.2026.07.021_bib0006","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40472-021-00350-1","article-title":"Hepatitis C positive organ donation in heart transplantation","volume":"8","author":"Siddiqi","year":"2021","journal-title":"Curr Transplant Rep"},{"issue":"15","key":"10.1016\/j.transproceed.2026.07.021_bib0007","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1001\/jama.296.15.1843","article-title":"Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients","volume":"296","author":"Gasink","year":"2006","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.transproceed.2026.07.021_bib0008","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJMoa1812406","article-title":"Heart and lung transplants from HCV-infected donors to uninfected recipients","volume":"380","author":"Woolley","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.transproceed.2026.07.021_bib0009","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.athoracsur.2022.11.002","article-title":"Outcomes of over 1000 heart transplants using hepatitis C-positive donors in the modern era","volume":"115","author":"Kwon","year":"2023","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.transproceed.2026.07.021_bib0010","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.healun.2018.01.1293","article-title":"Early outcomes using hepatitis C-positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies","volume":"37","author":"Schlendorf","year":"2018","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"10.1016\/j.transproceed.2026.07.021_bib0011","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/hep.31060","article-title":"Hepatitis C Guidance 2019 update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for testing, managing, and treating hepatitis C virus infection","volume":"71","author":"Ghany","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.transproceed.2026.07.021_bib0012","first-page":"250","article-title":"Addressing extreme propensity scores via the overlap weights","volume":"188","author":"Li","year":"2019","journal-title":"Am J Epidemiol"},{"issue":"23","key":"10.1016\/j.transproceed.2026.07.021_bib0013","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/jama.2020.7819","article-title":"Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial","volume":"323","author":"Thomas","year":"2020","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.transproceed.2026.07.021_bib0014","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.transproceed.2020.10.035","article-title":"Clinical experience of patients with hepatitis c treated with direct-acting antivirals after heart transplantation","volume":"53","author":"Lu","year":"2021","journal-title":"Transplant Proc"},{"issue":"10","key":"10.1016\/j.transproceed.2026.07.021_bib0015","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S2468-1253(19)30240-7","article-title":"Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study","volume":"4","author":"Bethea","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.transproceed.2026.07.021_bib0016","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13989","article-title":"Outcomes of the treatment with glecaprevir\/pibrentasvir following heart transplantation utilizing hepatitis C viremic donors","volume":"34","author":"Reyentovich","year":"2020","journal-title":"Clin Transplant"},{"issue":"7","key":"10.1016\/j.transproceed.2026.07.021_bib0017","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S2468-1253(20)30081-9","article-title":"Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study","volume":"5","author":"Feld","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.transproceed.2026.07.021_bib0018","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.31011","article-title":"Hepatitis C virus NAT-positive solid organ allografts transplanted into hepatitis C virus-negative recipients: a real-world experience","volume":"72","author":"Kapila","year":"2020","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.transproceed.2026.07.021_bib0019","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.healun.2016.01.1231","article-title":"Racial and ethnic disparities in outcomes after heart transplantation: A systematic review of contributing factors and future directions to close the outcomes gap","volume":"35","author":"Morris","year":"2016","journal-title":"J Heart Lung Transplant"},{"issue":"19","key":"10.1016\/j.transproceed.2026.07.021_bib0020","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.038892","article-title":"Racial disparities in heart transplantation: long-term graft survival and nonmortality outcomes","volume":"14","author":"Hamilton","year":"2025","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.transproceed.2026.07.021_bib0021","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1253\/circj.CJ-17-0162","article-title":"Heart transplantation in Asia","volume":"81","author":"Lee","year":"2017","journal-title":"Circ J"},{"issue":"22","key":"10.1016\/j.transproceed.2026.07.021_bib0022","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1056\/NEJMoa1613512","article-title":"Sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infection","volume":"376","author":"Bourli\u00e8re","year":"2017","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.transproceed.2026.07.021_bib0023","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13510","article-title":"Interactions between anti-infective agents and immunosuppressants-guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Sparkes","year":"2019","journal-title":"Clin Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134526003775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134526003775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:48:15Z","timestamp":1790426895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134526003775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0041134526003775"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.07.021","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Outcomes of Heart Transplantation Using Hepatitis C\u2013Positive Donors","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}